Stag Industrial (NYSE: STAG) and Vertex Pharmaceuticals (NASDAQ: VRTX) are off to a good start this year, and some industry tailwinds look to really boost shares in the coming years. Stag, which rents out warehouse space to commercial tenants, is benefiting from the reshoring trend. Vertex, already a leader in cystic fibrosis treatment, is on the tip of a gene-editing revolution.

Let's take a closer look at why these two potentially explosive stocks are buy candidates in May.

Stag is a real estate investment trust (REIT) that specializes in renting out single-tenant industrial properties with triple-net leases. As of Dec. 31, it owned 562 properties across 40 states. Its shares are up more than 7% this year. And thanks to long-term macro trends, I see continued growth for this stock which just joined the S MidCap 400.

Continue reading

Source Fool.com